VEGFA and neoplasm: Thus, the key finding was that a significant concurrence of VEGFA amplification/polysomy and its overexpression in the tumor was observed in Control Disease patients, which was not found in the Rapid Progressor patients, where gene amplification/polysomy did not correspond to protein-increased expression in the tumor.